Company intelligence / Profile preview

Puzzle Medical Devices

Ownership: Private
Development stage: Preclinical

Overview

The company’s ModulHeart™ percutaneous transcatheter heart pump has completed successful acute in-vivo preclinical implantations and received FDA Breakthrough Device Designation in February 2021. Human feasibility studies are ongoing as of mid–2025. No commercial sales or pivotal trial data reported yet.

Therapeutic areas: Cardiovascular
Modalities: DeviceMechanical circulatory support device (transcatheter heart pump)
Industry: Therapeutic Medical Devices

Partnerships

KF MathesonDesjardins CapitalLumira VenturesLongview VenturesBDC Capital

Beyond the preview

Go deeper on Puzzle Medical Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puzzle Medical Devices.

Explore the full profile